GANX Long Put Strategy
GANX (Gain Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. It is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. The company was founded in 2017 and is based in Bethesda, Maryland.
GANX (Gain Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $75.9M, a beta of 0.15 versus the broader market, a 52-week range of 1.41-4.34, average daily share volume of 684K, a public-listing history dating back to 2021, approximately 23 full-time employees. These structural characteristics shape how GANX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.15 indicates GANX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long put on GANX?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current GANX snapshot
As of May 15, 2026, spot at $1.77, ATM IV 198.10%, IV rank 44.88%, expected move 56.79%. The long put on GANX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long put structure on GANX specifically: GANX IV at 198.10% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 56.79% (roughly $1.01 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GANX expiries trade a higher absolute premium for lower per-day decay. Position sizing on GANX should anchor to the underlying notional of $1.77 per share and to the trader's directional view on GANX stock.
GANX long put setup
The GANX long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GANX near $1.77, the first option leg uses a $1.77 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GANX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GANX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $1.77 | N/A |
GANX long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
GANX long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on GANX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on GANX
Long puts on GANX hedge an existing long GANX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying GANX exposure being hedged.
GANX thesis for this long put
The market-implied 1-standard-deviation range for GANX extends from approximately $0.76 on the downside to $2.78 on the upside. A GANX long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long GANX position with one put per 100 shares held. Current GANX IV rank near 44.88% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on GANX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, GANX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GANX-specific events.
GANX long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GANX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GANX alongside the broader basket even when GANX-specific fundamentals are unchanged. Long-premium structures like a long put on GANX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current GANX chain quotes before placing a trade.
Frequently asked questions
- What is a long put on GANX?
- A long put on GANX is the long put strategy applied to GANX (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With GANX stock trading near $1.77, the strikes shown on this page are snapped to the nearest listed GANX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are GANX long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the GANX long put priced from the end-of-day chain at a 30-day expiry (ATM IV 198.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GANX long put?
- The breakeven for the GANX long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GANX market-implied 1-standard-deviation expected move is approximately 56.79%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on GANX?
- Long puts on GANX hedge an existing long GANX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying GANX exposure being hedged.
- How does current GANX implied volatility affect this long put?
- GANX ATM IV is at 198.10% with IV rank near 44.88%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.